Precision BioSciences doses first patient in Phase 1/2 PBGENE-DMD Duchenne gene-editing trial
D
DTIL• First patient dosed in PBGENE-DMD trial
•
Precision BioSciences doses first patient in Phase 1/2 PBGENE-DMD Duchenne gene-editing trial - DTIL News | Rallies
